S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

TVTX Travere Therapeutics Inc

17.84

0.44 (2.53%)

Dec 20 2024 - Closed

Delayed by 15 minutes

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

null

Travere Therapeutics (NASDAQ:TVTX)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Travere Therapeutics Charts.

Travere Therapeutics (NASDAQ:TVTX)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Travere Therapeutics Charts.

Travere Therapeutics Inc News

Form 4 - Statement of changes in beneficial ownership of securities
Monday 25 November 2024 (4 weeks ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Monday 25 November 2024 (4 weeks ago) • Edgar (US Regulatory)

Travere Therapeutics to Present at Upcoming Investor Conferences
Monday 25 November 2024 (4 weeks ago) • GlobeNewswire Inc.

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Thursday 14 November 2024 (1 month ago) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Thursday 14 November 2024 (1 month ago) • Edgar (US Regulatory)

Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Wednesday 13 November 2024 (1 month ago) • GlobeNewswire Inc.

Travere Therapeutics Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares
Tuesday 12 November 2024 (1 month ago) • GlobeNewswire Inc.

Form 8-K - Current report
Friday 8 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Friday 8 November 2024 (1 month ago) • Edgar (US Regulatory)

Travere Therapeutics Announces Pricing of Public Offering of Common Stock
Thursday 7 November 2024 (1 month ago) • GlobeNewswire Inc.

Travere Therapeutics Announces Proposed Public Offering of Common Stock
Thursday 7 November 2024 (1 month ago) • GlobeNewswire Inc.

Form 424B5 - Prospectus [Rule 424(b)(5)]
Thursday 7 November 2024 (1 month ago) • Edgar (US Regulatory)

More Travere Therapeutics Inc News Articles

GNCC Capital (CE)

Intergrated Cannabis Sol... (PK)

Asia Broadband (PK)

Elite Pharmaceuticals (QB)

North Bay Resources (PK)

Lightwave Logic

Digital Brand Media and ... (PK)

Anavex Life Sciences

Kraig Biocraft Laborator... (QB)

Fannie Mae (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions